NCT06250829View on ClinicalTrials.gov

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

May 30, 2025

Conditions
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
Interventions
OTHER

Observational

Observational study of body composition, cytokine profile, immune status, ctDNA, serial radiology.

Trial Locations (1)

N6A 5W9

RECRUITING

London Regional Cancer Program, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER